Cresco Labs (CRLBF) Exchange Rate Effect (2020 - 2026)
Cresco Labs (CRLBF) posted Exchange Rate Effect of -$200000.0 for Q1 2026, up 14.53% on a QoQ basis from -$234000.0 in Q3 2025, and down 1766.67% year-over-year from $12000.0 in Q1 2025.
Cresco Labs (CRLBF) Exchange Rate Effect (2020 - 2026) Analysis & Trends
Cresco Labs' Exchange Rate Effect history runs 7 years deep, the most recent figure standing at -$200000.0 for Q1 2026.
- Quarterly Exchange Rate Effect fell 1766.67% year-over-year to -$200000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $208000.0 (up 278.18% YoY) and the FY2024 annual result came in at -$39000.0, up 37.1% from the prior year.
- Exchange Rate Effect was -$200000.0 for Q1 2026 at Cresco Labs, up from -$234000.0 in the prior quarter.
- Across five years, Exchange Rate Effect topped out at $630000.0 in Q2 2025 and bottomed at -$313000.0 in Q1 2024.
- A 5-year average of -$1916.7 and a median of $8000.0 in 2023 frame the typical range for Exchange Rate Effect.
- Annual changes were most pronounced in 2024 — Exchange Rate Effect jumped 2271.43% — and 2026, when it tumbled 1766.67%.
- Cresco Labs' Exchange Rate Effect stood at $44000.0 in 2022, then plunged by 150.0% to -$22000.0 in 2023, then soared by 140.91% to $9000.0 in 2024, then plunged by 2700.0% to -$234000.0 in 2025, then increased by 14.53% to -$200000.0 in 2026.
- Business Quant data shows CRLBF's Exchange Rate Effect at -$200000.0 in Q1 2026, -$234000.0 in Q3 2025, and $630000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -17.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 17.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 7.01 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | -4.20 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -5.00 Mn |
| 10 | Cresco Labs | 254.96 Mn | 99.57 Mn | 75.45 Mn | -200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -200,000.00 |
| Mar 31, 2026 | -200,000.00 |
| Sep 30, 2025 | -234,000.00 |
| Sep 30, 2025 | -234,000.00 |
| Jun 30, 2025 | 630,000.00 |
| Jun 30, 2025 | 630,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Mar 31, 2025 | 12,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Sep 30, 2024 | 166,000.00 |
| Jun 30, 2024 | -132,000.00 |
| Jun 30, 2024 | -132,000.00 |
| Mar 31, 2024 | -313,000.00 |
| Mar 31, 2024 | -313,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | 7,000.00 |
| Sep 30, 2023 | 7,000.00 |